Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia.

Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia.
复制标题

DOI:
10.1086/591629
复制
发表时间:
2008-10-01
期刊:
The Journal of infectious diseases
影响因子:
--
通讯作者:
Rodriguez-Barradas MC
Rodriguez-Barradas MC
中科院分区:
其他
文献类型:
--
作者:
Musher DM;Rueda AM;Nahm MH;Graviss EA;Rodriguez-Barradas MC

文献摘要

参考文献

相似文献

肺炎球菌多糖疫苗(PPV)对高危成人的益处一直存在争议。我们对从肺炎球菌肺炎康复的成人进行了PPV、蛋白结合肺炎球菌疫苗(PCV),以及先用PCV进行免疫“启动”然后用PPV进行“加强”的研究。 受试者先接种PPV,6个月后接种PCV,或者顺序相反。在每次接种后的基线、4 - 8周和6个月时,对荚膜多糖的IgG和调理吞噬杀伤活性(OPK)进行研究。 在4 - 8周时,PPV和PCV刺激产生的IgG水平和OPK相似。接种PPV 6个月后,抗体降至基线水平,但接种PCV后仍有适度升高。在接种PPV 6个月后接种PCV,刺激IgG适度升高,但未达到接种PPV后的峰值。相比之下,在接种PCV 6个月后接种PPV,导致所有多糖的IgG和OPK大幅升高,符合加强效应。然而,在第二次接种6个月后,所有患者的IgG和OPK急剧下降,恢复到最初的基线水平。 在高危受试者中,PPV的效果是短暂的;PCV激发的反应更持久。在PCV之后使用PPV作为加强针会导致早期抗体升高,但此后IgG迅速下降,这与抑制细胞的诱导或免疫耐受相符。高危成人可能需要蛋白疫苗。
Controversy persists over the benefits of pneumococcal polysaccharide vaccine (PPV) in at-risk adults. We studied PPV, protein-conjugate pneumococcal vaccine (PCV), or immunologic ‘priming’ with PCV followed by ‘boosting’ with PPV in adults who recovered from pneumococcal pneumonia. Subjects received PPV followed in 6 months by PCV, or vice-versa. IgG to capsular polysaccharide and opsonophagocytic killing activity (OPK) were studied at baseline, 4–8 weeks and 6 months after each vaccination. PPV and PCV stimulated similar IgG levels and OPK at 4–8 weeks. Six months post-PPV, antibody declined to baseline but remained modestly elevated post-PCV. PCV given 6 months post-PPV stimulated modest IgG increases that failed to reach post-PPV peaks. In contrast, PPV 6 months after PCV caused dramatic increases in IgG and OPK to all polysaccharides, consistent with a booster effect. Six months after the second vaccination, however, IgG and OPK in all patients fell precipitously, returning toward original baseline levels. In high-risk subjects, the effect of PPV is short-lived; PCV stimulates a more prolonged response. PPV as a booster following PCV causes early antibody rises, but IgG declines rapidly thereafter, consistent with induction of suppressor cells or tolerance. Protein vaccines may be needed for high-risk adults.
DOI: 10.1097/00006454-200003000-00003
发表时间: 2000-03-01
影响因子: 3.6
作者:
Black, S;Shinefield, H;Edwards, K
通讯作者: Edwards, K
DOI: 10.1093/infdis/173.1.83
发表时间: 1996-01-01
影响因子: 6.4
作者:
Ahmed, F;Steinhoff, MC;Nelson, KE
通讯作者: Nelson, KE
DOI: 10.1016/j.vaccine.2007.02.062
发表时间: 2007-05-16
期刊: VACCINE
影响因子: 5.5
作者:
Jackson, Lisa A.;Neuzil, Kathleen M.;Carlone, George M.
通讯作者: Carlone, George M.
DOI: 10.1128/cdli.10.4.616-621.2003
发表时间: 2003-07-01
期刊: CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
影响因子: --
作者:
Kim, KH;Yu, JU;Nahm, MH
通讯作者: Nahm, MH
DOI: 10.1097/01.inf.0000207484.52850.38
发表时间: 2006-04-01
影响因子: 3.6
作者:
Gonzalez, BE;Hulten, KG;Mason, EO
通讯作者: Mason, EO